To determine if eliminating the prophylactic placement of a pelvic drain (PD) after robot-assisted radical prostatectomy (RARP) affects the incidence of early (90-day) postoperative adverse events.
Patients and Methods
In this parallel-group, blinded, non-inferiority trial, we randomised patients planning to undergo RARP to one of two arms: no drain placement (ND) or PD placement. Patients with demonstrable intraoperative leakage upon bladder irrigation were excluded. Randomisation sequence was determined a priori using a computer algorithm, and included a stratified design with respect to low vs intermediate/high D'Amico risk classifications. Surgeons remained blinded to the randomisation arm until final eligibility was verified at the end of the RARP. The primary endpoint was overall incidence of 90-day complications which, based on our standard treatment using PD retrospectively, was estimated at 13%. The non-inferiority margin was set at 10%, and the planned sample size was 312. An interim analysis was planned and conducted when onethird of the planned accrual and follow-up was completed, to rule out futility if the delta margin was in excess of 0.1389.
Results
From 2012 to 2016, 189 patients were accrued to the study, with 92 patients allocated to the ND group and 97 to the PD group. Due to lower than expected accrual rates, accrual to the study was halted by regulatory entities, and we did not reach the intended accrual goal. The ND and PD groups were comparable for median PSA level (6.2 vs 5.8 ng/mL, P = 0.5), clinical stage (P = 0.8), D'Amico risk classification (P = 0.4), median lymph nodes dissected (17 vs 18, P = 0.2), and proportion of patients receiving an extended pelvic lymph node dissection (70.7% vs 79.4%, P = 0.3). Incidence of 90-day overall and major (Clavien-Dindo grade >III) complications in the ND group (17.4% and 5.4%, respectively) was not inferior to the PD group (26.8% and 5.2%, respectively; P < 0.001 and P = 0.007 for difference of proportions <10%, respectively). Symptomatic lymphocoele rates (2.2% in the ND group, 4.1% in the PD group) were comparable between the two arms (P = 0.7).
Introduction
For clinically localised prostate cancer, radical prostatectomy (RP) is the 'gold standard' surgical treatment and remains one of the most frequently performed urological interventions [1] . Over time, ongoing technique refinements have led to excellent disease control, with improved continence and potency outcomes. Yet the benefit and necessity of certain measures performed during RP have yet to be determined. One such practice is the prophylactic placement of a pelvic drain (PD) after surgery to serve as a conduit for the removal of urine, blood, lymph and other fluid. In many centres, pelvic drainage remains a routine part of open and minimally invasive RP, despite the lack of high-level evidence of clinical benefit.
Robot-assisted RP (RARP) now comprises the majority of RPs performed in the USA [2] . With three-dimensional optical magnification and seven degrees of wrist range of motion, robotic surgery enables meticulous tissue dissection. RARP has been associated with lower intraoperative blood loss, fewer transfusions, and lower overall complications compared to the open approach [2] . Through improved surgical technique and the adoption of robotic surgery, the benefit and necessity of routine pelvic drainage after RARP in the contemporary setting has come into question.
Any adjustment to surgical technique that reduces patient discomfort, no matter how minor, deserves consideration. PDs have been associated with higher patient morbidity, infections, prolonged hospital stays, increased postoperative pain at the drain site, and an additional bedside procedure for removal with the potential for breakage and retention of drain material [3] [4] [5] [6] [7] [8] [9] . As such, PD omission after RARP could reduce morbidity without increasing complications. In the present randomised prospective non-inferiority study, we sought to determine the impact of eliminating PD placement after RARP with respect to the incidence of early postoperative adverse events (within 90 days).
Patients and Methods

Study Design and Randomisation
Our study was a single-centre, prospective, randomised, parallel-group trial. Eligible patients with prostate cancer who were scheduled for RARP and elected to be randomised for a PD vs no drain (ND) were consented and enrolled in our Institutional Review Board-approved study (Fig. 1) . Patients with prior radiotherapy and prior extensive pelvic surgery were excluded. The surgeon decided final eligibility after the vesicourethral anastomosis was tested with instillation of 120 mL normal saline to insure no leakage. If the patient had an anastomotic leak, inadequate haemostasis, or presence of an intraoperative injury, then the patient was given a PD and excluded from the study. A total of five patients (Table 1) were excluded.
Eligible patients were randomised to either ND group (Arm I) or the PD group (Arm II) using stratified randomisation before surgery. Randomisation sequence was determined a priori, and patients were assigned to the study arm according to the sequence, based on the order in which they registered for the protocol and their level of D'Amico risk (low vs intermediate/ high). The surgeon and operating staff were blinded to the designation arm until testing of the vesicourethral anastomosis. Only at this point, the randomisation envelope was opened and the study arm revealed.
From September 2012 to April 2016, 189 men underwent RARP for clinically localised prostate cancer and were randomised prospectively to ND (92 patients) or PD placement (97). The study was forced to early closure by regulatory entities at our institution due to accrual rates that were significantly lower than expected.
Surgical Technique
RARP was performed through a six-port transperitoneal approach using the four-arm da Vinci robotic surgical system â (Intuitive Surgical, Sunnyvale, CA, USA; both Si and Xi systems used) by four high-volume surgeons at a single institution. Pelvic lymph node dissection (PLND) was performed depending on D'Amico risk category, with extended LND (ELND) performed on intermediate-and high-risk patients. Per the surgeon's discretion, some lowrisk patients with high-volume disease underwent a limited LND (LLND), which included the obturator fossa and the area overlying the external iliac vein. Our ELND technique included as boundaries the ureteric crossing of the common iliacs proximally, the lateral border of the external iliac artery laterally, the node of Cloquet distally, as well as the obturator fossa [10] . When possible, the extents of dissection were controlled with Weck clips and divided. Lymph nodes (LNs) were sent in two packets (right and left pelvic LNs) in LLND and 11 packets in ELND (bilateral common, external and internal iliacs, node of Cloquet, obturator and anterior bladder fat). A bladder neck-sparing procedure, preservation of neurovascular bundles, and bladder neck reconstruction were performed according to surgeon's discretion. Rocco posterior reconstruction to minimise tension on the vesicourethral anastomosis was routinely performed. Adjuvant haemostatic agents were not routinely used by the surgeons. Patients' randomised to PD placement had a Jackson-Pratt drain placed anterior to the anastomosis through one of the lateral port sites and secured with a 2-0 silk suture.
Perioperative Management
Pharmacological anticoagulation was not routinely administered, although sequential compression devices and early ambulation were standard of care. Perioperative i.v. cephalosporin was administered for 24 h. Diets were advanced to clear liquids on postoperative day (POD) 1. PDs were removed at the attending surgeon's discretion, which was expected to occur between POD 1 or 2, when PD output was deemed low, and/or drain creatinine levels were consistent with serum in patients who had elevated outputs (i.e. >100 mL over 8 h). Foley catheters remained in place until POD 5-7. Cystography was not routinely performed at the time of Foley catheter removal.
Data Collection
A complete review of medical records, progress notes, outpatient charts and any outside records during hospitalisation and after discharge was performed by academic urologists. All complications within 90 days of RARP were recorded and graded according to the modified Clavien-Dindo classification system [11] , then reported using the established Martin criteria [12] . Ileus was defined as a delay in return of bowel function >5 days after RARP, the need for parenteral nutrition, or insertion of a nasogastric tube. Routine pelvic imaging was not performed; therefore, lymphocoeles and deep venous thrombosis were only diagnosed if symptomatic. Clavien-Dindo Grade I-II complications were considered minor and Grade III-V complications were considered major.
Statistical Analysis
The trial was designed with the aim of demonstrating noninferiority with regards to incidence of 90-day complications (Clavien-Dindo Grade I-V) in ND vs PD after RARP. We used our institution's retrospective prostate cancer database to estimate the complication rate for the standard of care of PD patients at 13%. Then, using a 10% margin in a binomial non-inferiority trial setting for comparing difference of proportions, and allowing for a 10% attrition rate, we aimed to accrue 312 patients or 156 in each arm of the study A delta margin in excess of 0.1389 for complication incidence between the two groups and favouring the PD group was set as the futility rule for the interim analysis, which was planned and conducted when one-third of the patients had completed the study (52 in each arm). To ensure the specified type-1 error probability, a group sequential analysis was done with East software with the Lan-DeMets a-spending function method. After the interim analysis, personnel changes and a decline in patient preference for randomisation caused the trial to stop for reasons unrelated to outcomes. Hence, the final analysis for the study was conducted before achieving the accrual goal, when about two-thirds of the desired number of patients had been accrued. Thus, we adjusted the a threshold to 0.016 (Lan-DeMets) for the primary study endpoint, taking a more conservative approach in interpretation of results. For our primary aim, we relayed results in the form of CIs (98.4%, to adjust for loss of type I error) for the difference of complication incidence rates between the two arms (ND -PD). Univariable and multivariable logistic regression analysis were used to determine whether the odds of early postoperative adverse events were significantly different between groups, whilst controlling for confounding prognostic factors.
Categorical data were reported as counts and percentages and continuous variables were reported as medians and interquartile ranges (IQRs 
Results
Between the two arms, baseline characteristics (Table 2) , and the proportion of patients receiving an ELND (Table 3) were not statistically significantly different. Figure 2 shows the distribution of the highest Clavien-Dindo complication grade for each patient by study arm. The incidence of 90-day overall complications (Table 3) in the ND group (17.4%) was not inferior to that in the PD group (26.8%). The À9.4% (98.4% CI: À23.8, 5.0) difference favouring the ND group clears the difference of proportions <10% (P < 0.001). Similarly, the incidence of 90-day major complications in the ND group (5.4%) was not inferior to that in the PD group (5.2%). The 0.28% (98.4% CI: À8.1, 7.6) difference favouring the PD groups clears the difference of proportions <10% (P = 0.007).
Overall, 42 patients (22.2%, Table 4 In univariable analysis (Table 5) 
Discussion
PD placement after RP has been a standard component of the procedure since its initial description [13] . Over the past two decades, the surgical management of localised prostate cancer has undergone important changes with the advent of robotics. Contemporary series have shown the morbidity of RARP to be low with short-term complications including anastomotic leakage, prolonged lymph drainage, rectal injury, symptomatic lymphocoele, pelvic abscess or hematoma occurring in <1-3% [14] . Yet, there remains a lack of contemporary high-level evidence about the usefulness of routine PD placement in these uncommon complications. Given the undetermined benefit of PD placement and the current lack of large prospective randomised trials directly addressing this issue, we performed the present study and made several notable findings. .2) (1.7, 11.6) Difference (P1-P2): 0.28% (95% CI -6.1, 6.7) P = 0.007* *P value reflects the probability that the upper limit of the CI of the difference of proportions (P1-P2) is below the 10% non-inferiority margin. First, the incidence of overall and major postoperative adverse events was similar in men who underwent RARP regardless of whether the pelvis was drained. Previous researchers have supported the safety of PD omission in open and minimally invasive RP series [3] [4] [5] [6] 8, 15] . However, the present study is the first in which patients who underwent RARP were randomised prospectively to PD omission and showed noninferiority.
Traditionally, PDs are placed to allow the egress of urine, blood and lymphatic fluid. However, the present study showed that clinical judgment was sufficient to omit a PD without significantly increasing the risk of complications. If an anastomotic urinary leak is found, a complex bladder neck reconstruction is performed, or clinical suspicion of an anastomotic leak exists, we advocate PD placement. Based on previous studies showing a strong correlation between intraoperative assessments of the vesicourethral anastomosis with saline instillation and subsequent low leak rate on follow-up cystogram [8, 16] , an experienced surgeon's judgment of the integrity of the anastomosis is reliable. In the present study, when the anastomosis was watertight upon intraoperative testing and a PD was omitted, the leak rate was low. However, four (2.1%) of the 189 patients [two in the ND group (2.2%) and two in the PD group (2.1%)] had an anastomotic leak on follow-up cystogram. Even though three of the four patients underwent prolonged Foley catheter We also demonstrated no difference in the symptomatic lymphocoele rate after PD omission, with similar proportion of patients undergoing ELND in each cohort. The incidence of symptomatic lymphocoele was actually higher in the PD group (4/97, 4.1%) compared to the ND group (2/92, 2.1%), although not statistically significant. Three of the four patients in the PD group with a symptomatic lymphocoele underwent percutaneous drainage, whilst neither of the two patients in the ND group underwent percutaneous drainage. With our institution's incorporation of a robotic transperitoneal approach, it allows for wide-open communication between the area of dissected LNs and the peritoneal cavity where the lymph fluid may be easily reabsorbed. Through this approach, the overall lymphocoele rate has been shown to be lower compared to the open approach [3, 17, 18] . Furthermore, international guidelines have recommended performing an ELND whenever lymphadenectomy is indicated [1, 19] . Some have reported that ELND-related lymphocoele formation depends predominantly on the extent of lymphadenectomy [14, 20, 21] . However, we previously reported our experience and the extent of PLND did not affect the symptomatic lymphocoele rate [22] .
Venous thromboembolic (VTE) events after RARP are rare, although patients are susceptible as a result of pelvic manipulation, malignancy, and stasis (Virchow's triad). Interestingly, our VTE rate of 3.2%, which is higher than most contemporary RARP series (<1%) [14] , may be attributed to the high percentage of patients undergoing PLND (89.4%). Retrospective series have reported that increasing LN yield significantly increases the postoperative symptomatic VTE rate [23, 24] . However, in our previous comparison of robot-assisted LLND (median LN yield of seven and VTE rate of 2.9%) and ELND (median LN yield of 21.5 and VTE rate of 1%), patients showed no difference in VTE rates by removing more LNs [22] . Nonetheless in the present series, even though the overall rate was high, the presence of a PD had no bearing on VTEs (2.2% in the ND group vs 4.1% in the PD group).
We recognise that placement of a PD is indicated with questionable haemostasis, demonstrable leakage at the anastomosis, or upon suspected injury to adjacent organs. However, routine placement of a PD may lead to additional morbidity including abdominal wall haematomas, pain at the drain site, wound infection at the drain site, injury to the inferior epigastric vessels, or retention of the distal fenestrated portion of PDs [6, 7, 25, 26] . To our knowledge the incidence of complications directly attributable to the Jackson-Pratt drain in the setting of a RP is unknown. However, one series has reported returning four patients to the operating room to locate and cut sutures that entrapped the Jackson-Pratt drain, preventing its removal [5] . Additionally, Niesel et al. [9] investigated post-RP pain and found it attributable to the drain site in 42 of 179 (24%) patients. In the present study, the pain attributable to the PD was not a primary endpoint, thus the contribution of PD to increased narcotic use is only speculative.
The strengths of the present study include the randomised prospective design to remove selection bias and minimise confounding prognostic factors. However, the low incidence of individual complications and the relatively low sample size, may not allow adequate detection of differences in these complications. In regards to the accrual issue, there is no doubt the 2011 USA Preventive Services Task Force (USPSTF) grade D recommendation against PSA-based screening for prostate cancer and active surveillance protocols have negatively affected RARP volume nationwide [27, 28] , and our institution is no exception. However, the biggest challenge we faced for accrual was convincing patients to opt for randomisation as several eligible patients simply refused and instead preferred to follow the surgeon's routine course, which in many cases did not include routine PD placement. Further, although a 90-day evaluation of complications captures most events related to the procedure, occasional late 
Conclusion
In similar cohorts of patients who underwent RARP, the incidence of overall and major postoperative adverse events in the ND group was not inferior to the group who received a PD. Rates of symptomatic lymphocoele appear to be similar. In properly selected patients, the use of a PD after RARP can be safely omitted without significant additional morbidity.
